These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16239203)

  • 1. Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control.
    Bergenstal RM; Nag SS; Reusch JE; Sajjan SG; Alexander CM
    Endocr Pract; 2005; 11(3):172-9. PubMed ID: 16239203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
    Raman R; Gupta A; Kulothungan V; Sharma T
    Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis.
    Kar D; Gillies C; Zaccardi F; Webb D; Seidu S; Tesfaye S; Davies M; Khunti K
    Cardiovasc Diabetol; 2016 Nov; 15(1):158. PubMed ID: 27881170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
    Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid intima-media thickness values are significantly higher in patients with prediabetes compared to normal glucose metabolism.
    Bulut A; Avci B
    Medicine (Baltimore); 2019 Nov; 98(44):e17805. PubMed ID: 31689862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
    Ahmed AA; Alsharief E; Alsharief A
    Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic health and vascular complications in type 1 diabetes.
    Bhattarai S; Godsland IF; Misra S; Johnston DG; Oliver N
    J Diabetes Complications; 2019 Sep; 33(9):634-640. PubMed ID: 31248795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease.
    Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ
    J Diabetes Complications; 2016; 30(1):115-20. PubMed ID: 26481154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes outcomes in specialist and general practitioner settings in Singapore: challenges of right-siting.
    Wee SL; Tan CG; Ng HS; Su S; Tai VU; Flores JV; Khoo DH
    Ann Acad Med Singap; 2008 Nov; 37(11):929-35. PubMed ID: 19082199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study.
    Selvin E; Coresh J; Golden SH; Boland LL; Brancati FL; Steffes MW;
    Diabetes Care; 2005 Aug; 28(8):1965-73. PubMed ID: 16043740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.